Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to

Juan Carlos López-Azor1, Juan Francisco Delgado2, Jorge Vélez3

  • 1Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain; Facultad de Medicina, Universidad Europea, Madrid, Spain.

Insights

Left ventricular ejection fraction (LVEF) significantly impacts heart failure (HF) patient costs and healthcare resource utilization. Patients with reduced LVEF (HFrEF) incurred higher costs, particularly those requiring hospitalization, compared to preserved LVEF (HFpEF) patients.

Area of Science:

  • Cardiology
  • Health Economics
  • Healthcare Management

Background:

  • The economic burden and resource utilization associated with different left ventricular ejection fraction (LVEF) categories in heart failure (HF) patients remain incompletely understood.
  • Understanding these disparities is crucial for optimizing healthcare resource allocation and patient management strategies.

Purpose of the Study:

  • To compare health care resource utilization (HCRU) and associated costs among patients with heart failure (HF) stratified by LVEF.
  • To investigate the impact of reduced (HFrEF), mildly reduced (HFmrEF), and preserved (HFpEF) ejection fraction on clinical outcomes and economic factors.

Main Methods:

  • A retrospective observational study analyzed data from 1287 patients with a primary HF diagnosis in Spain (2018).
  • Patients were categorized into HFrEF, HFmrEF, and HFpEF groups.
  • One-year clinical outcomes, HCRU, and costs were compared across these LVEF groups.

Main Results:

  • Patients with HFrEF exhibited higher hospitalization rates and significantly greater median annual costs (€4763 in ED group, €6321 in hospital group) compared to HFmrEF and HFpEF groups.
  • The increased costs in HFrEF patients were attributed to more frequent intensive care unit admissions and greater utilization of diagnostic and therapeutic interventions.
  • Overall median costs were €1889 for the ED group and €5008 for the hospital group, with significant differences observed across LVEF categories (P <.001).

Conclusions:

  • Left ventricular ejection fraction is a significant determinant of healthcare costs and resource utilization in heart failure patients.
  • HFrEF is associated with substantially higher healthcare expenditures, particularly for patients requiring hospitalization, underscoring the need for targeted management strategies.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
21
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
25
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
17